Regulatory effects of interleukin-6 in immunoglobulin G immune-complex- induced lung injury

American Journal of Pathology

Volumn 151, Issue 1, 1997, Pages 193-203

  Shanley, Thomas P ^a   Foreback, Jami L ^a   Remick, Daniel G ^a   Ulich, Thomas R ^b   Kunkel, Steven L ^a   Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE DIFFERENTIATION FACTOR; IMMUNOGLOBULIN G; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HEMATOPOIETIC CELL; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; LUNG LAVAGE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RAT; REGULATORY MECHANISM; RESPIRATORY DISTRESS SYNDROME; TARGET CELL;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; BRONCHOALVEOLAR LAVAGE FLUID; CELL SEPARATION; IMMUNE COMPLEX DISEASES; IMMUNE SERA; IMMUNOGLOBULIN G; INTERLEUKIN-6; LUNG; MALE; RATS; RATS, INBRED STRAINS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030874305     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Van Snick J: Interleukin-6: an overview. Annu Rev Immunol 1990, 8:253-278
2. Wong GG, Clark SC: Multiple actions of interleukin-6 within a cytokine network. Immunol Today 1988, 9:137-139
3. Hirano TT, Taga N, Nakano K, Yasukawa S, Kashiwamura K, Shimizu K, Nakajima KH, Pyun, Kishimoto T: Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci USA 1985, 85:5490-5494
4. Takai Y, Wong G, Clark S, Burakoff S, Herrmann S: B-cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J Immunol 1988, 140:508-512
5. Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y, Ogawa M: Interleukin-6 enhancement of interleukin-3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 1987, 84:9035-9039
6. Donnelly TJ, Meade P, Jagels M, Cryer G, Lae MM, Hugli TE, Shoemaker WC, Abraham E: Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury. Crit Care Med 1994, 22:768-776
7. Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, Umberger R, Leeper K: Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Chest 1995, 107:1062-1073
8. Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M: Cytokine serum levels during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1991, 215:356-366
9. Schluter B, Konig B, Bergmann U, Muller F, Konig W: Interleukin 6, a potential mediator of lethal sepsis after major thermal trauma: evidence for increased IL-6 production by peripheral blood mononuclear cells. J Trauma 1991, 31:1663-1670
10. Svoboda P, Kantorova I, Ochmann J: Dynamics of interleukin 1, 2, and 6 and tumor necrosis factor α in multiple trauma patients. J Trauma 1994, 36:336-340
11. Hoch RC, Rodriguez R, Manning T, Bishop M, Mead P, Shoemaker W, Abraham E: Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 1993, 21:839-845
12. Roumen T, Hendriks J, van der Ven-Jongekrijg GA, Nieuwenhuijzen R, Sauerwein W, van der Meer JWM, Goris RJA: Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Ann Surg 1993, 218:769-776
13. Ayala A, Wang P, Baz F, Perrin MM, Ertel W, Chaudry IH: Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. Am J Physiol 1991, 260: R167-R171
14. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T: The complex pattern of cytokines in serum from patients with meningococcal septic shock. J Exp Med 1989, 169:333-338
15. Ulich TR, Yin S, Quo K, Yi ES, Remick D, del Castillo J: Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor-β inhibit acute inflammation. Am J Pathol 1991, 138:1097-1101
16. Ulich TR, Quo K, Remick D, del Castillo J, Yin S: Endotoxin-induced cytokine gene expression in vivo, III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6. J Immunol 1990, 146:2316-2326
17. Denis M: Interleukin-6 in mouse hypersensitivity pneumonitis: changes in lung free cells following depletion of endogenous IL-6 or direct administration of IL-6. J Leukocyte Biol 1992, 52:197-201
18. Aderka D, Le J, Vilcek J: IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 1989, 143:3517-3523
19. Mulligan MS, Ward PA: Immune complex-induced lung and dermal vascular injury: differing requirements for TNF-α and IL-1. J Immunol 1992, 149:331-339
20. Gennari R, Alexander JW: Anti-interleukin-6 antibody treatment improves survival during gut-derived sepsis in a time-dependent manner by enhancing host defense. Crit Care Med 1995, 23:1945-1953
21. Chirgwin JM, Pryzbyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979, 18:5294-5299
22. Northemann W, Braciak TA, Hattori M, Lee F, Fey GH: Structure of the rat interleukin 6 gene and its expession in macrophage-derived cells. J Biol Chem 1989, 264:16072-16082
23. Aarden LA, DeGroot ER, Shaap OL, Landsdorp PM: Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987, 17:1411-1416
24. Warren JS, Yabroff KR, Remick DG, Kunkel SL, Chensue SW, Kunkel RG, Johnson KJ, Ward PA: Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J Clin Invest 1989, 84:1873-1882
25. Laemmli UK: Cleavage of structural proteins during assembly of the bacteriophage T4. Nature 1970, 227:680-685
26. Schmal H, Shanley TP, Jones ML, Friedl HP, Ward PA: Role for macrophage inflammatory protein-2 (MIP-2) in lipopolysaccharide-induced lung injury in rats. J Immunol 1995, 156:1963-1972
27. Fong Y, Moldawer LL, Marano M, Wei H, Tatter SB, Clarick RH, Santhanam U, Sherris D, May LT, Sehgal PB, Lowry SF: Endotoxemia elicits increased circulating β2-IFN/IL-6 in man. J Immunol 1989, 142:2321-2324
28. Mulligan MS, Wilson GP, Todd RF, Smith CW, Anderson DC, Varani J, Issekutz TB, Myasaka M, Tamatani T, Rusche JR, Vaporciyan AA, Ward PA: Role of β1, β2 integrins and ICAM-1 in lung injury after deposition of IgG and IgA immune complexes. J Immunol 1993, 150:2407-2417
29. Mulligan MS, Varani J, Dame MK, Lane CL, Smith CW, Anderson DC, Ward PA: Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats. J Clin Invest 1991, 88:1396-1406
30. Mulligan MS, Vaporciyan AA, Miyasaka M, Tamatani T, Ward PA: Tumor necrosis factor-α regulates In vivo intrapulmonary expression of ICAM-1. Am J Pathol 1993, 142:1739-1749
31. Barton BE, Jackson JV: Protective role of interleukin-6 in the lipopolysaccharide-galactosamine septic shock model. Infect Immun 1993, 61:1496-1499
32. Barton BE, Shortall J, Jackson JV: Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model. Infect Immun 1996, 64:714-718
33. Shanley TP, Schmal H, Friedl HP, Jones ML, Ward PA: Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury. J Immunol 1995, 154:3454-3460
34. Van Damme JG, Opdenakker RJ, Simpson MR, Rubira S, Cayphas A, Vink, Billiau A, Van Snick J: Identification of the human 26-kD protein, Interferon β2, as a cell hybridoma/plasmacytoma growth factor induced by interleukin-1 and tumor necrosis factor. J Exp Med 1987, 165:914-919
35. Jablons DM, Mule JJ, McIntosh JK, Sehgal PB, May LT, Huang CM, Rosenberg SA, Lotze MT: IL-6/IFN-β-2 as a circulating hormone: induction by cytokine administration in humans. J Immunol 1989, 142:1542-1547
36. Heinrich PC, Castell JV, Andus T: Interleukin-6 and the acute phase response. Biochem J 1990, 265:621-636
37. Castell JV, Gomez-Lecchon MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Sehgal PB, Grieninger G, Tosato G: Regulation of the acute phase and immune responses: interleukin-6. Ann NY Acad Sci 1989, 557:87-99
38. Castell JV, Gomez-Lecchon MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC: Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 1989, 242:237-239
39. Alcorn JM, Fierer J, Chojkier M: The acute phase response protects mice from D-galactosamine sensitization to endotoxin and tumor necrosis factor-α. Hepatology 1992, 15:122-129
40. Szalai AJ, Briles DE, Volanakis JE:. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J Immunol 1995, 155:2557-2563
41. Mulligan MS, Desrochers PE, Chinnaiyan AM, Gibbs DF, Varani J, Johnson KJ, Weiss SJ: In vivo suppression of immune complex-induced alveolitis by secretory leukoproteinase inhibitor and tissue inhibitor of metallo-proteinases-2. Proc Natl Acad Sci USA 1993, 90:11523-11527